EP News: Allied Professionals

Quality of life (QOL) was a pre-specified secondary outcome in the Substrate and Trigger Ablation for Reduction of Atrial Fibrillation –Part II (STAR AF II) trial and the authors (Terricabras et al. JAMA Netw Open. 2020;3:e2025473. PMID: 33275151) sought to determine whether QOL measures were affected by procedural outcome. STAR AF II was a randomized controlled trial assessing 3 AF ablation strategies in patients with persistent AF. The patients were followed for 18 months after ablation and the primary outcome of freedom from AF lasting>30 seconds after a single procedure.
Source: Heart Rhythm - Category: Cardiology Authors: Source Type: research